The chart also follows the progress of applications resubmitted after mid-2015. For more detailed information on resubmitted applications, see the FDA Performance Tracker’s User Fee Goal Dates chart.
Click on any column header to sort. New molecular or biologic entities are indicated with an asterisk (*)